• Login
Wednesday, March 18, 2026
Geneva Times
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
Geneva Times
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
Home Switzerland

Lonza to relocate around 40 jobs from Switzerland to India

GenevaTimes by GenevaTimes
March 18, 2026
in Switzerland
Reading Time: 10 mins read
0
Lonza to relocate around 40 jobs from Switzerland to India
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter


Lonza to relocate around 40 jobs to India

Around 40 relocations have been confirmed to the Keystone-ATS news agency by both the Unia trade union and canton Valais.


Keystone-SDA

The Swiss biopharmaceutical contract manufacturer Lonza plans to relocate around 40 jobs, including some from Visp in canton Valais, to the Indian city of Hyderabad by the end of 2026.





Generated with artificial intelligence.


This content was published on


March 18, 2026 – 16:21

+Get the most important news from Switzerland in your inbox

“Lonza is extending its centralised services model, which currently covers finance, human resources, IT and purchasing, to take on additional functions such as quality (control), supply chain and marketing,” said the Lonza press office, contacted by the Keystone-ATS news agency on Wednesday.

More

Lonza sells its capsules division

More


Pharma supply chains

Lonza sells off its capsules division to British firm




This content was published on


Mar 7, 2026



The Swiss firm is selling its capsules and health ingredients business to Lone Star Funds for CHF2.3 billion ($3 billion).



Read more: Lonza sells off its capsules division to British firm


“The employees affected by this restructuring do not benefit from a collective labour agreement but from individual contracts,” Barbara Lanthemann, the industry union secretary at Unia Valais, told Keystone-ATS.

Precise figures not disclosed

“Certain activities and functions will be progressively transferred to our low-cost centres, including some functional positions currently based in Visp,” the multinational said, declining to cite numbers.

The figure of around 40 relocations was confirmed to Keystone-ATS by both the Unia trade union and canton Valais, although the number of employees at the Visp site was not disclosed by the company.

Join the debate:

“The creation of a new centre of excellence in Hyderabad”, after those in Manchester and San José (Costa Rica), “will increase productivity, strengthen our working methods globally and expand access to India’s vast talent pool. This strategic initiative will create scalable and sustainable capabilities, while enabling our core functions to support the short- and long-term financial and growth objectives of our global business,” Lonza said.

Welcome to Hyderabad

The choice to set up in India is no accident. Hyderabad is considered a global hub for IT and technology. The city of over ten million inhabitants is considered a major site for software development, artificial intelligence (AI), the pharmaceutical industry and biotechnology. Tech giants such as Microsoft, Google and Amazon have made very significant investments there in recent years.

Employees who do not wish to leave canton Valais for India should be offered the possibility of continuing their professional activities in Visp. “Lonza is committed, as far as possible, to finding internal solutions for the employees concerned in Visp and at other sites,” the company said.

“This initiative (Project Orbit) aims to ensure the scalable and sustainable functional support necessary for continued growth of our workforce at our main sites and markets, particularly in the areas of production, manufacturing and associated operational and commercial functions,” Lonza added.

The Basel-based firm has around 4,500 employees in Visp, of whom approximately 1,500 work in production. “This sector is not affected by this relocation,” Lanthemann said.

More

Lonza

More

Moderna stands by partnership with Lonza




This content was published on


Sep 25, 2023



Despite production of mRNA for the Covid-19 vaccine ending at the Lonza site in Visp, Moderna is maintaining its strategic partnership with the Valais company, assures the boss of the American group.



Read more: Moderna stands by partnership with Lonza


Adapted from French by AI/sb

We select the most relevant news for an international audience and use automatic translation tools to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication.  

Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.

If you have any questions about how we work, write to us at english@swissinfo.ch

Articles in this story

Read More

Previous Post

Starmer mulls compromise on migration reforms after backlash from MPs – POLITICO

Next Post

UConn Teammates Sarah Strong and Azzi Fudd Headline AP All-America 1st Team

Next Post
UConn Teammates Sarah Strong and Azzi Fudd Headline AP All-America 1st Team

UConn Teammates Sarah Strong and Azzi Fudd Headline AP All-America 1st Team

ADVERTISEMENT
Facebook Twitter Instagram Youtube LinkedIn

Explore the Geneva Times

  • About us
  • Contact us

Contact us:

editor@thegenevatimes.ch

Visit us

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin